(en) We thank Dr Lisi for her interest in our article and we are pleased to provide some additional information and clarifications in relation to their comments. First, as described in the methods, the literature review focused on identifying existing explicit lists (also referred to as explicit tools) of drug-drug interactions (DDIs) in the older people. [...]
Anrys, P., & Spinewine, A. (2022). An International Consensus List of Potentially Clinically Significant Drug-Drug Interactions in Older People: Clinical Utility? Journal of the American Medical Directors Association, 23(3), 522. https://doi.org/10.1016/j.jamda.2021.11.038 (Original work published 2022)